DAYTRANA Safety Questions, DAYTRANA Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about DAYTRANA. Our extensive database of DAYTRANA adverse events and DAYTRANA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about DAYTRANA
DAYTRANA Safety Reports
Total DAYTRANA reports: 112.DAYTRANA FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 16.
Take DAYTRANA Side Effects Survey or Share Your DAYTRANA Story. DAYTRANA Usage.
Showing 1-50 of 112 Next >
Health Professional from UNITED STATES reported DAYTRANA problem on Mar 07, 2007. Male patient, child 11 years of age, weighting 63.93 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: dermatitis contact. DAYTRANA dosage: unknown. Patient recovered.DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2007. Female patient, weighting 89.95 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: convulsion. DAYTRANA dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported DAYTRANA problem on Feb 02, 2007. Female patient, child 11 years of age, weighting 84.44 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: urticaria. DAYTRANA dosage: 20MG, TRANSDERMAL. During the same period patient was treated with STRATTERA. Patient recovered.
DAYTRANA problem was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, child 11 years of age, weighting 80.03 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: headache, urticaria. DAYTRANA dosage: 15MG, TRANSDERMAL. Patient recovered.
Physician from UNITED STATES reported DAYTRANA problem on Dec 21, 2006. Male patient was diagnosed with psychomotor hyperactivity and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site dermatitis, application site vesicles. DAYTRANA dosage: 20 MG EVERY MORNING, TRANSDERMAL. Patient recovered.
DAYTRANA problem was reported by a Health Professional from UNITED STATES on Dec 04, 2006. Male patient, weighting 140.9 lb, was diagnosed with psychomotor hyperactivity and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: angioedema. DAYTRANA dosage: 20 MG, TRANSDERMAL; 15 MG, TRANSDERMAL. Patient recovered.
Health Professional from UNITED STATES reported DAYTRANA problem on June 21, 2007. Male patient, 13 years of age, weighting 137.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. DAYTRANA dosage: unknown. Patient recovered.
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2007. Male patient, child 7 years of age, was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: akathisia, blood pressure increased, dystonia. DAYTRANA dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DAYTRANA problem on June 29, 2007. Male patient, child 9 years of age, weighting 48.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. DAYTRANA dosage: 2.2MG/HR 1 PER DAY TRANSDERMAL. Patient recovered.
DAYTRANA problem was reported by a Physician from UNITED STATES on June 14, 2007. Male patient, 20 years of age, weighting 164.9 lb, was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site irritation, petechiae, rash erythematous, rash maculo-papular, raynaud's phenomenon, scleroderma, vaccination complication. DAYTRANA dosage: unknown. During the same period patient was treated with INFLUENZA VACCINE, NEXIUM, CLONAZEPAM. Patient recovered.
Health Professional from NEW ZEALAND reported DAYTRANA problem on June 29, 2006. Female patient was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: syncope. DAYTRANA dosage: unknown. Patient recovered.
DAYTRANA problem was reported by a Physician from UNITED STATES on Aug 03, 2006. Male patient, 13 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: aggression, eye disorder. DAYTRANA dosage: 10 MG, TRANSDERMAL. During the same period patient was treated with CONCERTA. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DAYTRANA problem on Aug 03, 2006. Male patient, child 6 years of age, weighting 54.01 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, agitation, crying, physical assault, rebound effect. DAYTRANA dosage: 10 MG, TRANSDERMAL. During the same period patient was treated with ADDERALL, FOCALIN. Patient recovered.
DAYTRANA problem was reported by a Physician from UNITED STATES on Aug 11, 2006. Female patient was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: psychotic disorder. DAYTRANA dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DAYTRANA problem on Aug 23, 2006. Female patient, 31 years of age, weighting 186.1 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. DAYTRANA dosage: unknown. Patient recovered.
DAYTRANA problem was reported by a Physician from UNITED STATES on Aug 31, 2006. Male patient, child 3 years of age, weighting 38.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: ill-defined disorder, muscle contractions involuntary, tachycardia, tic, tongue disorder, vomiting. DAYTRANA dosage: unknown. During the same period patient was treated with CLONIDINE. Patient recovered.
Physician from UNITED STATES reported DAYTRANA problem on Oct 06, 2006. Male patient, weighting 120.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: erythema, excoriation, pruritus, rash, skin irritation. DAYTRANA dosage: 20 MG DAILY TRANSDERMAL. During the same period patient was treated with STRATTERA, CONCERTA. Patient recovered.
DAYTRANA problem was reported by a Physician from UNITED STATES on Oct 04, 2006. Female patient, weighting 120.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site erythema, dry skin, pruritus, rash. DAYTRANA dosage: 20 MG DAILY TRANSDERMAL. During the same period patient was treated with ORAL CONTRACEPTIVE, BUPROPION. Patient recovered.
Physician from UNITED STATES reported DAYTRANA problem on Oct 03, 2006. Male patient, 13 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: aggression, eye disorder, physical assault. DAYTRANA dosage: 10 MG, TRANSDERMAL. During the same period patient was treated with CONCERTA. Patient recovered.
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2006. Male patient was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: blood pressure abnormal, electrocardiogram abnormal. DAYTRANA dosage: 10 MG, TRANDERMAL. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported DAYTRANA problem on Oct 16, 2006. Male patient, weighting 72.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: convulsion, dizziness, feeling abnormal, flushing, hyperhidrosis, loss of consciousness, nausea, syncope. DAYTRANA dosage: unknown. Patient recovered.
DAYTRANA problem was reported by a Physician from UNITED STATES on Oct 19, 2006. Male patient was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, confusional state, disorientation, memory impairment. DAYTRANA dosage: 10 MG QD. Patient recovered.
Physician from UNITED STATES reported DAYTRANA problem on Oct 11, 2006. Male patient was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. DAYTRANA dosage: 10 MG, TRANSDERMAL. Patient was hospitalized. Patient recovered.
DAYTRANA problem was reported by a Pharmacist from UNITED STATES on Oct 26, 2006. Male patient, weighting 91.93 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: chest pain, coordination abnormal, hypoaesthesia. DAYTRANA dosage: unknown. During the same period patient was treated with STRATTERA. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DAYTRANA problem on Oct 19, 2006. Male patient, 13 years of age, weighting 80.03 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: aggression, condition aggravated, homicidal ideation, oppositional defiant disorder. DAYTRANA dosage: 20 MG, TRANSDERMAL. Patient recovered.
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Male patient, child 8 years of age, was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site rash, flushing, hyperhidrosis, lip swelling, psychomotor hyperactivity, tachycardia, tardive dyskinesia. DAYTRANA dosage: 20 MG DAILY, TRANSDERMAL. During the same period patient was treated with RISPERIDONE, CLONIDINE. Patient recovered.
Pharmacist from UNITED STATES reported DAYTRANA problem on Oct 24, 2006. Male patient, child 11 years of age, weighting 104.1 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: heat exhaustion, loss of consciousness. DAYTRANA dosage: 15 MG , DAILY, TRANSDERMAL. Patient recovered.
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 31, 2006. Male patient, 38 years of age, weighting 160.1 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site oedema, application site pruritus, application site reaction, application site swelling, scar. DAYTRANA dosage: 30 MG, TRANSDERMAL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DAYTRANA problem on Oct 31, 2006. Male patient was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: convulsion, tremor. DAYTRANA dosage: unknown. Patient recovered.
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2006. Female patient, child 12 years of age, weighting 108.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: arthralgia, cough, nasopharyngitis, oedema peripheral, sinusitis. DAYTRANA dosage: 15 MG TRANSDERMAL. During the same period patient was treated with NASONEX, LORATADINE, VITAMINS. Patient recovered.
Physician from UNITED STATES reported DAYTRANA problem on Oct 31, 2006. Female patient, child 9 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site rash, rash vesicular. DAYTRANA dosage: 20 GM TRANSDERMAL ; 15 MG TRANSDERMAL. During the same period patient was treated with PROZAC. Patient recovered.
DAYTRANA problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Male patient, weighting 141.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, dyspnoea, eye swelling, swollen tongue. DAYTRANA dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DAYTRANA problem on Nov 10, 2006. Male patient, child 9 years of age, weighting 63.05 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, convulsion. DAYTRANA dosage: 10 MG X 2, TRANSDERMAL; 10 MG, TRANSDERMAL. During the same period patient was treated with TRACROLIMUS, VALGANCICLOVIR, METOCLOPRAMIDE, PRILOSEC, KEPPRA, TRILEPTAL, VITAMINS. Patient recovered.
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2006. Male patient, child 6 years of age, weighting 42.99 lb, was diagnosed with attention deficit/hyperactivity disorder, bipolar disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: dystonia, hot flush, parkinsonism, prescribed overdose, vomiting. DAYTRANA dosage: TWO 30-MG PATCHES, TRANSDERMAL. During the same period patient was treated with ZYPREXA, FOCALIN, RITALIN LA. Patient recovered.
Physician from UNITED STATES reported DAYTRANA problem on Nov 14, 2006. Female patient, child 9 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site vesicles, rash erythematous. DAYTRANA dosage: 20 MG, TRANSDERMAL; 10 MG TRANSDERMAL. During the same period patient was treated with PROZAC, ADDERALL. Patient recovered.
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2006. Male patient, child 7 years of age, was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site pain. DAYTRANA dosage: 15 MG, TRANSDERMAL. During the same period patient was treated with NEXIUM, TAGAMET. Patient recovered.
Physician from UNITED STATES reported DAYTRANA problem on Nov 15, 2006. Male patient, child 9 years of age, weighting 110.0 lb, was diagnosed with asperger's disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site inflammation, application site rash, application site reaction, off label use, rash erythematous, rash papular. DAYTRANA dosage: 10 + 15 MG ONE AND 1/ 2 PATCHES, TRANSDERMAL - SEE IMAGE. During the same period patient was treated with RITALIN. Patient recovered.
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2006. Male patient, child 10 years of age, weighting 91.93 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, hypoaesthesia, non-cardiac chest pain. DAYTRANA dosage: 10 MG, TRANSDERMAL. During the same period patient was treated with STRATTERA. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported DAYTRANA problem on Nov 28, 2006. Male patient, child 11 years of age, weighting 72.09 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: convulsion, dyskinesia, flushing, hyperhidrosis, malaise, nausea, syncope. DAYTRANA dosage: 10 MG, TRANSDERMAL. During the same period patient was treated with STRATTERA, RITALIN. Patient recovered.
DAYTRANA problem was reported by a Physician from UNITED STATES on Nov 30, 2006. Male patient, child 9 years of age, weighting 69.89 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. DAYTRANA dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DAYTRANA problem on Nov 30, 2006. Male patient, child 8 years of age, weighting 56.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: decreased appetite, insomnia, visual acuity reduced. DAYTRANA dosage: 20 MG, TRANSDERMAL. During the same period patient was treated with REMERON, ZYRTEC, SINGULAIR. Patient recovered.
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 30, 2006. Female patient, child 9 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site rash, decreased appetite, delusion, paranoia. DAYTRANA dosage: 15 MG, TRANSDERMAL, SEE IMAGE. During the same period patient was treated with RITALIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DAYTRANA problem on Nov 30, 2006. Male patient, child 10 years of age, weighting 91.93 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, hypoaesthesia, non-cardiac chest pain. DAYTRANA dosage: 10 MG, TRANSDERMAL. During the same period patient was treated with STRATTERA, NAPROXEN. Patient was hospitalized. Patient recovered.
DAYTRANA problem was reported by a Physician from UNITED STATES on Nov 27, 2006. Female patient was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site erythema. DAYTRANA dosage: unknown. Patient recovered.
Health Professional from UNITED STATES reported DAYTRANA problem on Dec 07, 2006. Female patient was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: psychotic disorder. DAYTRANA dosage: unknown. During the same period patient was treated with CONCERTA. Patient recovered.
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2006. Male patient, child 7 years of age, weighting 57.10 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. DAYTRANA dosage: 10MG, TRANSDERMAL. Patient recovered.
Physician from UNITED STATES reported DAYTRANA problem on Dec 12, 2006. Male patient, child 9 years of age, weighting 69.89 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. DAYTRANA dosage: unknown. Patient recovered.
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 11, 2006. Male patient, child 5 years of age, weighting 50.04 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site dermatitis, application site erythema, application site hypersensitivity, dermatitis contact, rash. DAYTRANA dosage: 30 MG, TRANSDERMAL. During the same period patient was treated with STRATTERA. Patient recovered.
Health Professional from UNITED STATES reported DAYTRANA problem on Dec 19, 2006. Female patient, weighting 90.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: convulsion, depressed level of consciousness, loss of consciousness. DAYTRANA dosage: unknown. Patient was hospitalized. Patient recovered.
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 15, 2006. Male patient, child 7 years of age, weighting 57.10 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: erythema infectiosum. DAYTRANA dosage: 10MG, TRANSDERMAL. Patient recovered.
Showing 1-50 of 112 Next >